Painful HIV sensory neuropathy can greatly impact quality of life in patients with HIV/acquired immunodeficiency syndrome (AIDS). 1 Despite extensive research, the exact neuropathological mechanisms of painful sensory neuropathy responsible for the development of this devastating condition remain unknown. Neurologic dysfunction is believed to depend on cellular entry of HIV, which requires sequential interactions between the envelope protein gp120 with CD4 glycoprotein [2] [3] [4] [5] and chemokine receptors on the cell surface. [6] [7] [8] [9] HIV gp120 is believed to exert both direct and indirect neurotoxic effects in the nervous system through the release of proinflammatory molecules. 10 A growing body of evidence in a variety of animal models suggests that proinflammatory cytokines, such as tumor necrosis factor-α (TNF-α) released by the activated spinal glial cells and in the dorsal root ganglia (DRG), are critical to enhancing pain. [11] [12] [13] [14] [15] [16] Phosphorylated p38 mitogen-activated kinase (p-p38), a member of the family of mitogen-activated protein kinases (MAPKs), is strongly associated with TNF-α expression in the chronic pain state. 17 The expression of p-p38 in the DRG is well characterized after peripheral nerve injury associated with pathological pain. 17, 18 The BACKGROUND: Human immunodeficiency virus (HIV)-associated sensory neuropathy is a common neurological complication of HIV infection affecting up to 30% of HIV-positive individuals. However, the exact neuropathological mechanisms remain unknown, which hinders our ability to develop effective treatments for HIV-related neuropathic pain (NP). In this study, we tested the hypothesis that inhibition of proinflammatory factors with overexpression of interleukin (IL)-10 reduces HIV-related NP in a rat model. METHODS: NP was induced by the application of recombinant HIV-1 envelope protein gp120 into the sciatic nerve. The hindpaws of rats were inoculated with nonreplicating herpes simplex virus (HSV) vectors expressing anti-inflammatory cytokine IL-10 or control vector. Mechanical threshold was tested using von Frey filaments before and after treatments with the vectors. The mechanical threshold response was assessed over time using the area under curves. The expression of phosphorylated p38 mitogen-activated kinase, tumor necrosis factor-α, stromal cell-derived factor-1α, and C-X-C chemokine receptor type 4 in both the lumbar spinal cord and the L4/5 dorsal root ganglia (DRG), was examined at 14 and 28 days after vector inoculation using Western blots. RESULTS: We found that in the gp120-induced NP model, IL-10 overexpression mediated by the HSV vector resulted in a significant elevation of the mechanical threshold that was apparent on day 3 after vector inoculation compared with the control vector (P < 0.001). The antiallodynic effect of the single HSV vector inoculation expressing IL-10 lasted >28 days. The area under curve in the HSV vector expressing IL-10 was increased compared with that in the control vector (P < 0.0001). HSV vectors expressing IL-10 reversed the upregulation of phosphorylated p38 mitogen-activated kinase, tumor necrosis factor-α, stromal cell-derived factor-1α, and C-X-C chemokine receptor type 4 expression at 14 and/or 28 days in the DRG and/or the spinal dorsal horn. CONCLUSIONS: Our studies demonstrate that blocking the signaling of these proinflammatory molecules in the DRG and/or the spinal cord using the HSV vector expressing IL-10 is able to reduce HIV-related NP . These results provide new insights on the potential mechanisms of HIVassociated NP and a proof of concept for treating painful HIV sensory neuropathy with this type of gene therapy. (Anesth Analg 2014;119:693-701) ANESTHESiA & ANAlgESiA C-X-C chemokine receptor type 4 (CXCR4) acts as an important inflammatory factor in the neuropathogenesis of HIV/AIDS. 19, 20 CXCR4 is required for gp120-induced cell death. 21 Importantly, our studies show that stromal cell-derived factor-1α (SDF-1α) and its receptor CXCR4 are involved in the gp120-induced NP. 22 Interleukin-10 (IL-10) is a critical pleiotropic antiinflammatory cytokine that blocks phosphorylation of MAPK pathways, resulting in the inhibition of MAPK actions. 23 IL-10 diminishes the levels of TNF mRNAs after the onset of stimulation of polymorphonuclear leukocytes with lipopolysaccharide (LPS, a very common proinflammatory inducer), identifying the biological actions of IL-10 as a suppressor of the inflammatory response. 24, 25 Lumbosacral administration of the IL-10 transgene or protein leads to robust suppression of tactile allodynia induced by sciatic nerve injury, as well as spinal inflammation after a single intrathecal injection of gp120 protein. [26] [27] [28] Hyperalgesic responses to TNF-α or carrageenan are inhibited by intraplantar administration of IL-10. 12 The highly replication-defective herpes simplex virus (HSV) genomic vectors can establish a persistent state that is used to deliver and express transgenes in the DRG neurons. The DRG neurons transduced with the HSV vector transport transgene-coded enkephalin centrally in the bipolar axon of the primary sensory afferents to the spinal dorsal horn (SDH). 29 Transduction of the DRG sensory neurons by footpad inoculation with the HSV-based vectors encoding human preproenkephalin gene produces an antihyperalgesic effect in models of acute thermal pain 30 and inflammatory pain. 31, 32 HSV vectors encoding preproenkephalin gene also induce physiological improvement in visceral pain induced by bladder irritation. 33 Inoculation of the HSV vectors expressing the IL-10 gene significantly reduces mechanical allodynia below the level of injury after blunt trauma to the spinal cord. 34 HIV NP with a sizeable morbidity is difficult to manage. 1 In this study, we tested the hypothesis that HSV vector-mediated IL-10 expression could treat NP induced by HIV gp120. We found that this IL-10 gene therapy produced antinociceptive effects on NP induced by the gp120 application to the sciatic nerve and reduced proinflammatory molecules p-p38, TNF-α, and CXCR4/SDF-1 in the DRG and/or the SDH.
METHODS A Nonreplicating HSV-Based Vector Expressing IL-10
HSV vector expressing IL-10 contains the full-length rat IL-10 gene tagged with hemagglutinin under the control of the human cytomegalovirus immediate-early promoter; the control vector contains the lacZ gene (Q0ZHG) in place of IL10-hemagglutinin. 34 The construction of IL-10 vectors has been described (designated in that report as QHIL10). 35 In our previous studies, we demonstrated that the vector produces IL-10 from the primary DRG neurons infected in vitro and in the spinal cord in vivo. 16 
Animals
Male Sprague-Dawley rats weighing 225 to 250 g were housed 1 to 3 per cage approximately 7 days before the beginning of the study. Rats were maintained with free access to food and water and were on a 12:12 light:dark schedule at 21°C and 60% humidity. All housing conditions and experimental procedures were approved by the University Animal Care and Use Committee and were conducted in accordance with the ethical guidelines of the International Association for the Study of Pain.
Perineural gp120 Neuropathic Pain Model
Under anesthesia, the rat's left sciatic nerve was exposed in the popliteal fossa without damaging the nerve construction. A 2-× 6-mm strip of oxidized regenerated cellulose was previously soaked in 250 μL of a 0.1% rat serum albumin in saline, containing 400 ng gp120 (Immunodiagnostics, Bedford, MA) or 0.1% rat serum albumin in saline for the sham surgery. A length of 3 to 4 mm of the sciatic nerve was wrapped loosely with the previously soaked cellulose, proximal to the trifurcation not to cause any nerve constriction and left in situ. 36, 37 The incision was closed with 4/0 sutures.
Mechanical Threshold
Rats were placed in nontransparent plastic cubicles on a mesh floor for an acclimatization period of at least 30 minutes on the morning of the test day. Mechanical threshold was determined by assessing paw withdrawal to von Frey filaments (Stoelting, Wood Dale, IL) of graded tensile strength. A series of calibrated von Frey filaments were presented serially to the hindpaw in ascending order of strength, with each filament applied for 6 seconds with sufficient force to cause slight bending against the paw. A positive response was defined as a rapid withdrawal and/or licking of the paw immediately on application of the stimulus. Whenever a positive response to a stimulus occurred, the next smaller von Frey hair was applied, and whenever a negative response occurred, the next higher force was applied. In the absence of a response at a pressure of 15.1 g, animals were assigned to this cutoff value. The tactile stimulus producing a 50% likelihood of withdrawal was determined using the up-and-down method. 11
Western Blots
The lumbar L4-5 DRG and the SDH ipsilateral to gp120 application were removed rapidly under deep anesthesia, frozen on dry ice, and stored at −80°C. These tissues were homogenized in protein lysis buffer (150 mM sodium chloride, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% sodium dodecyl sulfate, 50 mM Tris, pH 8.0) containing protease inhibitors and phosphatase inhibitors (phosphatase inhibitor cocktails 1/2). The homogenate was centrifuged at 18,000g for 20 minutes at 4°C. The supernatant was collected and assayed for protein concentration using the DC protein assay (Bio-Rad, Hercules, CA). Aliquots containing 30 μg protein were dissolved in Laemmli buffer and denatured at 95°C for 5 minutes; the proteins were separated by 10% Tris-glycine sodium dodecyl sulfate-polyacrylamide gel electrophoresis gel and transferred to a polyvinylidene difluoride membrane. The membranes were blocked with 5% nonfat dry milk in phosphate-buffered saline and then incubated with primary antibodies overnight at 4°C, including rabbit polyclonal anti-p-p38 IgG (1:1000, Santa Cruz Biotechnology, Santa Cruz, CA), rabbit polyclonal anti-TNF-α (1:500, Chemicon, Temecula, CA), goat anti-CXCR4 (1:1000, Santa Cruz Biotechnology), rabbit anti-SDF-1α (1:500, ABCAM, Cambridge, MA), and mouse anti-β-actin (1:8000, Sigma, St. Louis, MO). The blots were incubated with secondary antibodies (Santa Cruz Biotechnology), developed in chemiluminescence solution (Pierce Biotechnology, Rockford, IL). Quantification of Western blots was done from the obtained chemiluminescence values (ChemiDoc, Bio-Rad). Target protein bands were normalized using β-actin.
Drug and Data Analysis
Statistical analysis was performed with SPSS version 21 (IMB Corporation, Armonk, NY). The results describing behavioral responsiveness to von Frey stimulation that indicates mechanical sensitivity were given as a mechanical threshold. The values from each test group were graphed as mean ± SEM. The data, which incorporated the main effects for group and time, were analyzed using a 2-way analysis of variance (ANOVA) repeated measure. The group means and 95% confidence interval were calculated using SPSS. Differences in mean changes at the same time points were evaluated individually for the assessment of treatment effects on hypersensitivity with 2-tailed t tests. The area under curves (AUCs) data, depicting the mechanical threshold (g) over time, were calculated by the trapezoidal rule to express the overall magnitude and duration of effect and analyzed between 2 different treatments using a t test. The actual P values were shown in the figures.
The data for the effects of the HSV vector on the neurochemical changes among 3 groups were compared with 1-way ANOVA with post hoc Fisher protected least significant difference test (StatView5; SAS Institute Inc., Cary, NC). Given the small sample size and consequently the inability to assess the statistical assumptions for normality and equal variance, a stringent P value ≤0.01 was considered to be statistically significant in all ANOVA tests. 38 
RESULTS

The Effect of IL-10 Mediated by HSV Vector on Mechanical Allodynia Induced by gp120
Evidence has demonstrated that peripheral gp120 application into the sciatic nerve results in NP characterized by mechanical allodynia 12, 36, 37 and that gp120 induces upregulation of proinflammatory cytokines/chemokines (e.g., TNF-α, SDF-1) in the spinal cord and the sciatic nerve. 12, 22, 36 The knockdown of TNF-α using spinal TNF-α small interfering RNA reduces mechanical allodynia. 12 The principal anti-inflammatory activity of IL-10 is to inhibit the production of proinflammatory cytokines. 24 We have demonstrated that IL-10 mediated by the HSV vector reversed formalininduced inflammatory pain and spinal p-p38 and TNF-α. 16 Recent studies show that inoculation with the HSV vector expressing IL-10 reduces mechanical allodynia induced by spinal cord injury, which correlates with a significant decrease in spinal TNF-α. 34 In this study, we further examined whether overexpression of IL-10 mediated by the HSV vector reduced NP induced by HIV gp120. Subcutaneous inoculation with QHIL10 (30 μL containing 1 × 10 9 plaqueforming units/mL) was performed in the plantar surface of the hindpaw. QHIL10 resulted in a statistically significant elevation of the mechanical threshold that was apparent on day 3 after vector inoculation compared with the control vector (F (1, 13) = 43.82, P < 0.001, repeated measures ANOVA, n = 7-8, Fig. 1A ). The antiallodynic effect of the HSV vector lasted for >28 days. The group means of mechanical threshold with 95% confidence interval were 11.23 (9.61-12.84) in QHIL10 and 3.99 (2.26-5.71) in Q0ZHG. For comparison of the differences at individual time points between groups, we used a 2-tailed t test (P values are shown in Fig. 1A ). The AUC in the QHIL10 group was significantly higher than in the Q0ZHG group (P < 0.0001, t test, n = 7-8, Fig. 1B ).
The Effect of HSV Vector Overexpressing IL-10 on p-p38 in the DRG and SDH in the gp120 Model
In this study, we investigated whether the overexpression of IL-10 mediated by the HSV vector reduced p-p38 in the HIV-related NP state. The L4/5 DRG and spinal cord were harvested on day 14 after vector injection. Pooled L4/5 DRG and SDH were used for Western blots. In the DRG samples from day 14 after vector injection, expression of p-p38 in the gp120 + Q0ZHG group was significantly increased compared with that in the sham + Q0ZHG group (P = 0.0001, Fig. 2A ); expression of p-p38 in the gp120 + QHIL10 group was markedly lower than that in the gp120 + Q0ZHG group (P = 0.0003, Fig. 2A ). In the SDH samples from day 14 after vector injection, expression of p-p38 in the gp120 + Q0ZHG group was markedly increased compared with that in the sham + Q0ZHG group (P = 0.0011, Fig. 2B ); the expression level of p-p38 in the gp120 + www.anesthesia-analgesia.org
ANESTHESiA & ANAlgESiA QHIL10 group was less than that in the gp120 + Q0ZHG group (P = 0.0085, Fig. 2B) . Similarly, in a separate set of experiments, on day 28 after vector injection, the L4/5 DRG and spinal cord were harvested for Western blots. In the DRG, there was a significant increase in p-p38 in the gp120 + Q0ZHG group compared with that in the sham + Q0ZHG group (P = 0.0052, Fig. 2C ). However, the expression of p-p38 in the gp120 + QHIL10 group was not significantly different from that in the gp120 + Q0ZHG group (P = 0.073, Fig. 2C ). In SDH samples from day 28 after vector injection, p-p38 in the gp120 + Q0ZHG group was markedly increased compared with that in the sham + Q0ZHG group (P = 0.0068, Fig. 2D ). In the gp120 + QHIL10 group, p-p38 was less than that in the gp120 + Q0ZHG group, but the difference was not statistically significant (P > 0.01, Fig. 2D ).
The Effect of HSV Vector Overexpressing IL-10 on TNF-α in the DRG and SDH in the gp120 Model Accumulating evidence indicates that HIV gp120 mediated-NP increases TNF-α in the spinal cord and DRG. 12, 22 In the current study, we examined whether overexpression of IL-10 mediated by the HSV vector reduced TNF-α in NP induced by gp120. L4/5 DRG and spinal cord were harvested for Western blots on day 14 after vector injection. In the DRG, there was a marked increase in TNF-α in the gp120 + Q0ZHG group compared with that in the sham + Q0ZHG group (P < 0.0001, Fig. 3A ). TNF-α in the gp120 + QHIL10 group was significantly decreased compared with that in the gp120 + Q0ZHG group (P < 0.0001, Fig. 3A ). In the SDH, there was a marked increase in TNF-α in the gp120 + Q0ZHG group compared with that in the sham + Q0ZHG group (P < 0.0001, Fig. 3B ). TNF-α expression in the gp120 + QHIL10 group was significantly lower than that in the gp120 + Q0ZHG group (P < 0.0001, Fig. 3B ). Recent studies show that the HSV vector expressing IL-10 not only reduced mechanical allodynia induced by spinal cord injury, but also decreased TNF-α to the level of the sham group, 34 which was similar to the current study.
In similar studies, on day 28 after injection of the vector, L4/5 DRG and spinal cord were harvested for Western blots. In the DRG, there was a significant increase in TNFα in the gp120 + Q0ZHG group compared with that in the sham + Q0ZHG group (P = 0.0004, Fig. 3C ). The expression (SDH; B) were harvested, and the expression of TNF-α was tested using Western blots. The actual P values between sham + Q0ZHG and gp120 + Q0ZHG groups or between gp120 + Q0ZHG and gp120 + QHIL10 groups are shown in A and B, 1-way analysis of variance (ANOVA) with post hoc Fisher protected least significant difference (PLSD) test, mean ± SEM, n = 4 rats. C and D, On day 28 after vector injection, L4/5 DRG (C) and SDH (D) were harvested, and the expression of TNF-α was tested using Western blots. The actual P values between sham + Q0ZHG and gp120 + Q0ZHG groups or between gp120 + Q0ZHG and gp120 + QHIL10 groups are shown in C and D, 1-way ANOVA with post hoc Fisher PLSD test, mean ± SEM, n = 4 rats. and spinal cord at 14 or 28 days. Rats with neuropathic pain were inoculated with QHIL10 or Q0ZHG on day 7 after gp120 administration. In the sham group, rats received Q0ZHG. A and B, On day 14 after vector injection, the L4/5 DRG (A) and spinal dorsal horn (SDH; B) were harvested, and expression of p-p38 was tested using Western blots. The data among 3 groups were compared using 1-way analysis of variance (ANOVA) with post hoc Fisher protected least significant difference (PLSD) test, mean ± SEM, n = 4 rats. The actual P values between sham + Q0ZHG and gp120 + Q0ZHG group or between gp120 + Q0ZHG and gp120 + QHIL10 are shown in A and B. C and D, On day 28 after vector injection, L4/5 DRG (C) and SDH (D) were harvested, and the expression of p-p38 was tested using Western blots. The actual P values between sham + Q0ZHG and gp120 + Q0ZHG groups or between gp120 + Q0ZHG and gp120 + QHIL10 groups are shown in C and D, 1-way ANOVA with post hoc Fisher PLSD test, mean ± SEM, n = 4 rats.
of TNF-α in the DRG in the gp120 + QHIL10 group was decreased compared with that in the gp120 + Q0ZHG group (P = 0.0024, Fig. 3C ). In the SDH samples from day 28 after injection of the vector, there was a marked increase in TNFα in the gp120 + Q0ZHG group compared with that in the sham + Q0ZHG (P = 0.004, Fig. 3D ); TNF-α in the gp120 + QHIL10 group was significantly lower than that in the gp120 + Q0ZHG group (P = 0.0008, Fig. 3D ).
The Effect of HSV Vector Overexpressing IL-10 on SDF-1α in the DRG and SDH in the gp120 Model TNF-α enhances expression of CXCR4, which facilitates the chemotactic invasiveness of cultured human mesenchymal stem cells toward SDF-1α. 39 We have reported that IL-10 is able to suppress overexpression of mRNA and protein of TNF-α induced by formalin into the hindpaw. 16 However, it is not known whether IL-10 reduces production of SDF-1α in vivo in the gp120-induced NP state. In this study, we investigated whether the overexpression of IL-10 mediated by the HSV vector reduced SDF-1α in the NP state. In the DRG samples from day 14 after vector injection, there was a significant increase in SDF-1α in the gp120 + Q0ZHG group compared with that in the sham + Q0ZHG group (P = 0.0001, Fig. 4A ). The expression of SDF-1α in the DRG in the gp120 + QHIL10 group was markedly decreased compared with that in the gp120 + Q0ZHG group (P = 0.0003, Fig. 4A ). In SDH samples from day 14 after vector injection, there was a significant increase in SDF-1α in the gp120 + Q0ZHG group compared with that in the sham + Q0ZHG group (P < 0.0001, Fig. 4B ). SDF-1α in the gp120 + QHIL10 group was markedly decreased compared with that in the gp120 + Q0ZHG group (P < 0.0001, Fig. 4B ).
In the DRG on day 28 after injection of vectors, there was a significant increase in SDF-1α in the gp120 + Q0ZHG group compared with that in the sham + Q0ZHG group (P < 0.0001, Fig. 4C ). The expression of SDF-1α in the gp120 + QHIL10 group was decreased compared with that in the gp120 + Q0ZHG group (P < 0.0001, Fig. 4C ). In SDH samples from day 28 after injection of vectors, there was a statistically nonsignificant increase in SDF-1α in the gp120 + Q0ZHG group compared with that in the sham + Q0ZHG group (P > 0.01, Fig. 4D ). However, SDF-1α in the gp120 + QHIL10 group was markedly lower than that in the gp120 + Q0ZHG group (P = 0.0017, Fig. 4D ).
The Effect of the HSV Vector Overexpressing IL-10 on CXCR4 in the DRG and SDH in the gp120 Model
In the DRG on day 14 after vector injection, there was a statistically nonsignificant increase in CXCR4 in the gp120 + Q0ZHG group compared with that in the sham + Q0ZHG group (Fig. 5A) . The expression of CXCR4 in the gp120 + QHIL10 group was less than that in the gp120 + Q0ZHG group, but the difference was not statistically significant (Fig. 5A ). In the SDH, there was a significant increase in CXCR4 in the gp120 + Q0ZHG group compared with that in the sham + Q0ZHG group (P = 0.0014, Fig. 5B ). CXCR4 in the gp120 + QHIL10 group was markedly less than that in the gp120 + Q0ZHG group (P = 0.0009, Fig. 5B ).
In the DRG on day 28 after vector injection, CXCR4 tended to increase in the gp120 + Q0ZHG group compared with that in the sham + Q0ZHG group, but the difference was not statistically significant (Fig. 5C ). In the expression of CXCR4, there was statistically nonsignificant difference between the gp120 + QHIL10 and gp120 + Q0ZHG groups (Fig. 5C ). In the SDH samples from day 28 after vector injection, there was a significant increase in CXCR4 in the gp120 + Q0ZHG group compared with that in the sham + Q0ZHG group (P = 0.003, Fig. 5D ). CXCR4 in the gp120 + QHIL10 group was less than that in the gp120 + Q0ZHG group, but the difference was not statistically significant (Fig. 5D ).
DISCUSSION
The current study demonstrated that in a gp120-induced NP model, IL-10 mediated by the HSV vector resulted in a significant elevation of the mechanical threshold that was apparent on day 3 after vector inoculation. The antiallodynic effect of the HSV vector lasted >28 days. The AUC in the HSV vectors expressing IL-10 was increased compared with the control vector. The HSV vector expressing IL-10 reversed upregulation of p-p38, TNF-α, SDF-1α, and SDH; B) were harvested, and the expression of SDF-1α was tested using Western blots. The actual P values between sham + Q0ZHG and gp120 + Q0ZHG groups or between gp120 + Q0ZHG and gp120 + QHIL10 groups are shown in A and B, 1-way analysis of variance (ANOVA) with post hoc Fisher protected least significant difference (PLSD) test, mean ± SEM, n = 4 rats. C and D, On day 28 after vector injection, L4/5 DRG (C) and SDH (D) were harvested, and the expression of SDF-1α was tested using Western blots. The actual P values between sham + Q0ZHG and gp120 + Q0ZHG groups or between gp120 + Q0ZHG and gp120 + QHIL10 groups are shown in C and D, 1-way ANOVA with post hoc Fisher PLSD test, mean ± SEM, n = 4 rats.
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ANESTHESiA & ANAlgESiA CXCR4 induced by gp120 in the lumbar SDH and/or the DRG at 14 and/or 28 days. HIV-1 envelope protein gp120 has been implicated directly and indirectly in the pathogenesis of HIV-associated neurocognitive disorders. MAPKs such as p38 are important for intracellular signal transduction and play critical roles in regulating neural plasticity and inflammatory responses. 40 In in vitro studies, HIV gp120 activity unravels the involvement of p38 and resultant neurotoxic activity. 41, 42 The signaling of p38 is critical on exposure to HIV gp120 for the neurotoxic phenotype of monocytic cells. 43, 44 HIV uses the p38 pathway to produce new viruses and to deplete CD4 + T cells from the host's immune system. 45 In in vivo studies, Milligan et al. 46 have reported that the systemic p38 inhibitor CNI-1493 blocks intrathecal gp120-induced mechanical allodynia.
HIV infection is able to increase production of several cytokines. 47 It is reported that there is an increased level of TNF-α in the human cerebrospinal fluid, 48 blood plasma, 49 spinal cord, 50 and brain 51 in patients with HIV. The early presence of cytokines may be involved in induction and/or progression of HIV sensory neuropathy. For example, the HIV protein influences neuronal survival by increasing TNF-α production. 52 We and others have reported that application of recombinant gp120 to the sciatic nerve increases TNF-α in the DRG and spinal cord. 12, 36 Furthermore, intrathecal TNFα small interfering RNA or TNF soluble receptor reduces gp120 application-induced mechanical allodynia, indicating that TNF-α in the spinal cord and/or the DRG are involved in NP induced by HIV gp120. 12 TNF soluble receptor mediated by the HSV vector suppresses gp120-induced NP and reduces TNF-α. 22 Taken together, these data highlight the importance of TNF-α in the development of the exaggerated pain state related to HIV gp120.
A growing body of evidence shows that chemokines and their receptors play an important role in inducing and maintaining NP. 22, 53, 54 The interplay of TNF-α and HIV-1 leads to enhanced expression of toxic chemokines. 55 SDF-1α has multiple effects on neuronal activity, survival, and death under conditions that generate a proinflammatory microenvironment within the nervous system through its receptor CXCR4. 56 Considering the widespread expression of CXCR4 in the nervous system, CXCR4 and its ligand SDF-1α are important factors in the neuropathogenesis of HIV/AIDS. 19 HIV gp120 binds to and activates CXCR4 expressed by DRG neurons in a CD-4-independent manner, 57, 58 suggesting the direct neurotoxic effects of gp120 on neurons. 59 Recent studies have shown that HIV gp120 induces upregulation of SDF-1 and CXCR4 in the spinal cord and DRG at 2 weeks. 22 In the current studies, although neuropathic rats with Q0ZHG did not show a significant increase in spinal SDF-1α at 4 weeks (Fig. 4D ), there was a significant increase in the DRG (Fig. 4C) ; neuropathic rats with Q0ZHG had a trend to increase CXCR4, but did not significantly increase CXCR4 in the DRG at either 2 or 4 weeks (Fig. 5) .
The principal anti-inflammatory activities of IL-10 are to inhibit the production of proinflammatory cytokines. 24, 25 IL-10 diminishes TNF mRNA after the onset of stimulation of polymorphonuclear leukocytes with LPS, identifying the biological action of IL-10 as a suppressor of the inflammatory response. 24 In in vivo studies, IL-10 inhibited the writhing response induced by acetic acid or zymosan in mice and knee joint incapacitation induced by zymosan in rats. IL-10 also inhibited the release of TNF-α from mice peritoneal macrophages obtained after local injection of zymosan. 60 Acute intrathecal administration of rat IL-10 protein briefly reverses chronic constriction injury (CCI)-induced mechanical allodynia. 61 Hyperalgesic responses to TNF-α or carrageenan are inhibited by intraplantar administration of IL-10. 62 We have shown that IL-10 reduces p-p38 and expression of full-length membrane spanning TNF-α after LPS stimulation of microglia in vitro; IL-10 also reduces intracellular cleavage of membrane TNF-α and release of soluble TNF-α. 16 In in vitro studies, hypoxia-mediated increases in CXCR4 expression and cell survival are lower in IL-10-deficient endothelial progenitor cells. 63 IL-10 also downregulates CXCR4 mRNA expression in CD4 + T lymphocytes. 64 In the present study, we report for the first time that IL-10 suppresses SDF-1/CXCR4 in the NP state induced by gp120.
Viral vectors or plasmids overexpressing IL-10 may be a new approach to producing analgesia and antiallodynia C D A B Figure 5 . The effect of interleukin (IL)-10 mediated by herpes simplex virus (HSV) vectors on the expression of C-X-C chemokine receptor type 4 (CXCR4) in the dorsal root ganglia (DRG) and the spinal cord at 14 or 28 days. A and B, On day 14 after vector injection, L4/5 DRG (A) and spinal dorsal horn (SDH; B) were harvested, and the expression of CXCR4 was tested using Western blots. The actual P values between sham + Q0ZHG and gp120 + Q0ZHG groups or between gp120 + Q0ZHG and gp120 + QHIL10 groups are shown in A and B, 1-way analysis of variance (ANOVA) with post hoc Fisher protected least significant difference (PLSD) test, mean ± SEM, n = 4 rats. C and D, On day 28 after vector injection, L4/5 DRG (C) and SDH (D) were harvested, and expression of CXCR4 was tested using Western blots. The actual P values between sham + Q0ZHG and gp120 + Q0ZHG groups or between gp120 + Q0ZHG and gp120 + QHIL10 groups are shown in the C and D, 1-way ANOVA with post hoc Fisher PLSD test, mean ± SEM, n = 4 rats.
associated with a variety of pain states. Intrathecal delivery of plasmid DNA encoding IL-10 gene prevents and progressively reverses the allodynic state induced by paclitaxel (a chemotherapy drug) and markedly decreases paclitaxelinduced expression of TNF mRNA in the lumbar DRG. 65 Repeated intrathecal delivery of the plasmid DNA vectors encoding IL-10 gene abolishes NP induced by sciatic CCI. 26 Adenoviral vectors encoding the human IL-10 gene prevent and reverse mechanical allodynia in the CCI model 61 ; the adenoviral vectors expressing cytokine IL-10 also enhance acute morphine analgesia and attenuate the development of morphine tolerance, hyperalgesia, and allodynia. 66 Highly effective gene transfer to the primary sensory neurons of the DRG with self-complementary recombinant adeno-associated virus serotype 8 expressing IL-10 leads to significant reversal of mechanical allodynia in chronic NP induced by L5 spinal nerve ligation. 67 Our group has previously reported the expression of IL-10 by HSV vectors-transduced cells. 16 The cultured primary DRG neurons with these IL-10 vectors result in the release of IL-10. 16 We have found that transduction of DRG neurons in vivo achieved by subcutaneous inoculation of the vector in the foot results in production of transgene-coded IL-10 in DRG neurons and transport of the gene product to terminals in the spinal cord suppresses the formalininduced nociceptive effect and reduces spinal TNF-α and p-p38 expression. 16 In the present studies, IL-10 mediated by HSV significantly reversed the upregulation of TNF-α at 2 and 4 weeks; however, IL-10 reversed the upregulation of p-p38 at 2 weeks, but not at 4 weeks. The exact mechanisms by which IL-10 suppresses TNF-α or p-p38 are still not clear. IL-10 mediated by HSV almost totally reversed the upregulation of mRNA of TNF-α in the spinal cord in the formalin pain model. 16 Recent studies have shown that the HSV vectors expressing IL-10 not only reduced mechanical allodynia induced by spinal cord injury, but also decreased TNF-α to the level of their sham group, 34 which is similar to the current study ( Fig. 3 ). In our current study, we extend our previous results showing that IL-10 expressed by HSV vectors reduced NP induced by HIV gp120 administration into the sciatic nerve and reversed the upregulation of p-p38, TNF-α, SDF-1α, and CXCR4 induced by gp120 in the lumbar SDH and/or DRG at 14 and/or 28 days. Future work will study the detailed mechanisms/pathways by which IL-10 suppresses those inflammatory factors.
In summary, blocking proinflammatory molecules reduced HIV gp120-induced NP. These results support that the current novel proof-of-concept approach to gene therapy with HSV-mediated overexpression of IL-10 is an important new strategy for treating HIV-associated NP. E
